Skip to main content
Español

News: Timing of Metformin Important in Metformin-Treated Type 2 Diabetes

News & Articles (Drugs.com)

Outcomes TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3... More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug...

News: Metformin Use Linked to Lower Odds of Myeloproliferative Neoplasms

News & Articles (Drugs.com)

...-Term Healthy Dietary Patterns Linked to Healthy Aging FRIDAY, July 5, 2024 -- Higher long-term adherence to healthy dietary patterns is associated with an increased likelihood of healthy aging, according to a study presented at... More news resources FDA Medwatch Drug Alerts Daily MedNews News for...

News: Statins, Metformin Can Cut Odds for Brain Aneurysms

News & Articles (Drugs.com)

...measuring... Mediterranean Diet Ups Survival Odds After Cancer WEDNESDAY, July 3, 2024 -- The Mediterranean diet can help cancer survivors maintain their heart health and live longer, a new study says.Cancer patients whose eating patterns... More news resources FDA Medwatch Drug Alerts Daily MedNews News...

News: Paternal Metformin Use Not Linked to Major Congenital Malformations

News & Articles (Drugs.com)

Peripheral Insulin Sensitivity THURSDAY, June 27, 2024 -- Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the... More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug...

News: Continuing Metformin in Pregnancy Has Little Effect on Nonlive Birth

News & Articles (Drugs.com)

Sensitivity THURSDAY, June 27, 2024 -- Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the... More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug...

News: Using Diabetes Drug Metformin Around Pregnancy Won't Raise Birth Defect Risk

News & Articles (Drugs.com)

...risk of type 2 diabetes? Avoid bright light at night, a recent study suggests.More exposure to light at night, between 12:30 a.m... More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results...

FDA Approves Xigduo XR (dapagliflozin / metformin) for Glycemic Control in Children Aged 10 Years and Older with Type-2 Diabetes

New Drug Approvals (FDA)

Press Release Posted: June 2024 Related articles FDA Approves Xigduo XR (dapagliflozin and metformin hydrochloride) for Type 2 Diabetes - October 30, 2014 Xigduo XR (dapagliflozin and metformin hydrochloride) FDA Approval History More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health...

FDA Alert: Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)

Drug Alerts (FDA)

...by fax to 1-800-FDA-0178 This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Source: FDA More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results...

FDA Alert: SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin

Drug Alerts (FDA)

Glucose Support Supplement in 60, 120 and 180 count bottles to the consumer level. FDA analysis has found the product to be tainted with glyburide and metformin. Glyburide and Metformin are active ingredients found in several FDA-approved prescription drugs used to treat type 2 diabetes. Products...

FDA Alert: Marksans Pharma Limited Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)

Drug Alerts (FDA)

...voluntarily recalling Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004, to the consumer level. FDA analysis has found the product to contain N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit (ADI) of 96ng / day. Risk Statement: NDMA is classified as a...